PDL BioPharma, Inc (PDLI) Covered Calls

PDL BioPharma, Inc covered calls PDL BioPharma, Inc. is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.

You can sell covered calls on PDL BioPharma, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PDLI (prices last updated Mon 4:16 PM ET):

PDL BioPharma, Inc (PDLI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.69 +0.10 3.64 3.71 1.1M - 0.5B
Covered Calls For PDL BioPharma, Inc (PDLI)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Apr 18 4 0.05 3.66 1.4% 20.4%
May 17 4 0.15 3.56 4.2% 28.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. The company manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. PDL BioPharma was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.